MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Sodium clodronate

Sodium clodronate 400mg capsules

Incompatible

Stability notes for Sodium clodronate 400mg capsules

No special precautions for storage. However, the complex administration regime makes it unsuitable for MCA.

Supplier

Clasteon 400mg capsules (Kent Pharma (UK) Ltd)

Sodium clodronate 520mg tablets

Incompatible

Stability notes for Sodium clodronate 520mg tablets

No special precautions for storage. However, the complex administration regime makes it unsuitable for MCA.

Suppliers

Loron 520mg tablets (Esteve Pharmaceuticals Ltd)
Loron 520mg tablets (Sigma Pharmaceuticals Plc)

Sodium clodronate 800mg tablets

Incompatible

Stability notes for Sodium clodronate 800mg tablets

No special precautions for storage. However, the complex administration regime makes it unsuitable for MCA.

Supplier

Clasteon 800mg tablets (Kent Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.